Font Size:
a
A
A
Keyword [Platinum-Sensitive Recurrent Ovarian Cancer]
Result: 1 - 13 | Page: 1 of 1
1.
1 Nedaplatin And Paclitaxel Compared With Carboplatin And Paclitaxel For Patients With Platinum-Sensitive Recurrent Ovarian Cancer 2 Copy Number Variations Of Neurotrophic Tyrosine Receptor Kinase 3 (NTRK3) May Predict Prognosis Of Ovarian Cancer
2.
Factors Influencing The Efficacy Of Secondary Cytoreductive Surgery For Platinum Sensitive Recurrent Ovarian Cancer
3.
Analysis Of The Clinica And Pathologica Factors Affecting The Treatment Effect Of Platinum-sensitive Recurret Ovarian Cancer
4.
The Prognosis Of Hyerthermic Intraperitoneal Chemotherapy For Recurrent Ovarian Cancer:a Meta-analysis
5.
Pre-evaluation Of Satisfaction Degree With Secondary Cytoreductive Surgery For Platinum-sensitive Recurrent Ovarian Cancer
6.
Comparing And Analyzing The Prognosis Of Platinum-sensitive Recurrent Ovarian Cancer With Secondary Cytoreductive Surgery Combined With Chemotherapy And Simple Chemotherapy
7.
Analysis Of The Effectiveness And Safety Of Olaparib In Maintenance Treatment Of Platinum-sensitive Recurrent Ovarian Cancer
8.
The Study Of The Therapeutic Of Secondary Cytoreduction Surgery In Patients With Platinum Sensitive Recurrent Ovarian Cancer With Unsatisfactory Primary Cytoreduction Surgery
9.
Efficacy Of Fluzoparil In Maintenance Treatment Of Platinum Sensitive Recurrent Ovarian Cancer
10.
Study Of The Efficacy Of Different Treatments For Platinum-sensitive Recurrent Ovarian Cancer
11.
Study On The Role Of PARP Inhibitors In The Treatment Of PALB2 Mutation Platinum-sensitive Recurrent Ovarian Cancer
12.
Expression Of RAD51 Gene In Platinum-sensitive Recurrent Ovarian Cancer And Its Correlation With Parp Inhibitor(Niraparib)resistance
13.
Clinical Validation Of Prediction Models Of Complete Tumor Resection In Secondary Cytoreductive Surgery For Platinum-Sensitive Recurrent Ovarian Cancer
<<First
<Prev Next>
Last>>
Jump to